The amyloid precursor protein/protease nexin 2 Kunitz inhibitor domain is a highly specific substrate of mesotrypsin. 2010

Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
Department of Cancer Biology, Mayo Clinic Cancer Center, Jacksonville, Florida 32224, USA.

The amyloid precursor protein (APP) is a ubiquitously expressed transmembrane adhesion protein and the progenitor of amyloid-beta peptides. The major splice isoforms of APP expressed by most tissues contain a Kunitz protease inhibitor domain; secreted APP containing this domain is also known as protease nexin 2 and potently inhibits serine proteases, including trypsin and coagulation factors. The atypical human trypsin isoform mesotrypsin is resistant to inhibition by most protein protease inhibitors and cleaves some inhibitors at a substantially accelerated rate. Here, in a proteomic screen to identify potential physiological substrates of mesotrypsin, we find that APP/protease nexin 2 is selectively cleaved by mesotrypsin within the Kunitz protease inhibitor domain. In studies employing the recombinant Kunitz domain of APP (APPI), we show that mesotrypsin cleaves selectively at the Arg(15)-Ala(16) reactive site bond, with kinetic constants approaching those of other proteases toward highly specific protein substrates. Finally, we show that cleavage of APPI compromises its inhibition of other serine proteases, including cationic trypsin and factor XIa, by 2 orders of magnitude. Because APP/protease nexin 2 and mesotrypsin are coexpressed in a number of tissues, we suggest that processing by mesotrypsin may ablate the protease inhibitory function of APP/protease nexin 2 in vivo and may also modulate other activities of APP/protease nexin 2 that involve the Kunitz domain.

UI MeSH Term Description Entries
D007700 Kinetics The rate dynamics in chemical or physical systems.
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D011480 Protease Inhibitors Compounds which inhibit or antagonize biosynthesis or actions of proteases (ENDOPEPTIDASES). Antiprotease,Endopeptidase Inhibitor,Endopeptidase Inhibitors,Peptidase Inhibitor,Peptidase Inhibitors,Peptide Hydrolase Inhibitor,Peptide Hydrolase Inhibitors,Peptide Peptidohydrolase Inhibitor,Peptide Peptidohydrolase Inhibitors,Protease Antagonist,Protease Antagonists,Antiproteases,Protease Inhibitor,Antagonist, Protease,Antagonists, Protease,Hydrolase Inhibitor, Peptide,Hydrolase Inhibitors, Peptide,Inhibitor, Endopeptidase,Inhibitor, Peptidase,Inhibitor, Peptide Hydrolase,Inhibitor, Peptide Peptidohydrolase,Inhibitor, Protease,Inhibitors, Endopeptidase,Inhibitors, Peptidase,Inhibitors, Peptide Hydrolase,Inhibitors, Peptide Peptidohydrolase,Inhibitors, Protease,Peptidohydrolase Inhibitor, Peptide,Peptidohydrolase Inhibitors, Peptide
D011956 Receptors, Cell Surface Cell surface proteins that bind signalling molecules external to the cell with high affinity and convert this extracellular event into one or more intracellular signals that alter the behavior of the target cell (From Alberts, Molecular Biology of the Cell, 2nd ed, pp693-5). Cell surface receptors, unlike enzymes, do not chemically alter their ligands. Cell Surface Receptor,Cell Surface Receptors,Hormone Receptors, Cell Surface,Receptors, Endogenous Substances,Cell Surface Hormone Receptors,Endogenous Substances Receptors,Receptor, Cell Surface,Surface Receptor, Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013379 Substrate Specificity A characteristic feature of enzyme activity in relation to the kind of substrate on which the enzyme or catalytic molecule reacts. Specificities, Substrate,Specificity, Substrate,Substrate Specificities
D014357 Trypsin A serine endopeptidase that is formed from TRYPSINOGEN in the pancreas. It is converted into its active form by ENTEROPEPTIDASE in the small intestine. It catalyzes hydrolysis of the carboxyl group of either arginine or lysine. EC 3.4.21.4. Tripcellim,Trypure,beta-Trypsin,beta Trypsin
D015945 Factor XIa Activated form of factor XI. In the intrinsic pathway, Factor XI is activated to XIa by factor XIIa in the presence of cofactor HMWK; (HIGH MOLECULAR WEIGHT KININOGEN). Factor XIa then activates factor IX to factor IXa in the presence of calcium. Coagulation Factor XIa,Factor XI, Activated,Activated Factor XI,Blood Coagulation Factor XI, Activated,Contact Activation Product,Factor 11A,Factor Eleven A,Factor XIa, Coagulation

Related Publications

Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
July 1992, Biochemical and biophysical research communications,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
September 1989, Nature,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
February 1991, Biochemical and biophysical research communications,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
March 1990, Biochemical and biophysical research communications,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
February 1991, Gene,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
November 1993, The Journal of clinical investigation,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
June 2023, Journal of computational chemistry,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
November 1993, The Journal of clinical investigation,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
August 2013, Biochemical and biophysical research communications,
Moh'd A Salameh, and Jessica L Robinson, and Duraiswamy Navaneetham, and Dipali Sinha, and Benjamin J Madden, and Peter N Walsh, and Evette S Radisky
December 2005, Proceedings of the National Academy of Sciences of the United States of America,
Copied contents to your clipboard!